| Surgical Evacuation Versus Methotrexate Injection in Treatment of Caesarean Scar Pregnancy [Clinical Trial ] (NCT07288307) | Minia University | 2026-01-20 |
| A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors (NCT07263594) | DualityBio Inc. | 2026-01-20 |
| Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) (NCT07297563) | Institute of Hematology & Blood Diseases Hospital, China | 2026-01-20 |
| A Phase II Study of SKB571 in Patients With Lung Cancer (NCT07230405) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-01-19 |
| Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer (NCT07188246) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2026-01-19 |
| Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. (NCT07396337) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2026-01-19 |
| Circulating Tumor DNA Response In Urothelial Cancer (NCT07183319) | University of Oklahoma | 2026-01-19 |
| Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis (NCT07556393) | Inimmune Corporation | 2026-01-19 |
| 5G-PEARL: Paxalisib in Malignant Brain Tumours (NCT07391215) | Institute of Cancer Research, United Kingdom | 2026-01-19 |
| Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder (NCT07226661) | Supernus Pharmaceuticals, Inc. | 2026-01-19 |
| A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma (NCT07328009) | Fudan University | 2026-01-19 |
| Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia (NCT07373301) | Malaria Vaccine and Drug Development Center | 2026-01-19 |
| A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis (NCT07233655) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-01-19 |
| A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma (NCT07333469) | Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | 2026-01-19 |
| The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children (NCT07388615) | Al-Azhar University | 2026-01-18 |
| Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology (NCT06417190) | Leslie Ballas | 2026-01-16 |
| Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC (NCT07724223) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-16 |
| Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer (NCT07368543) | Fudan University | 2026-01-16 |
| A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis (NCT07315061) | InventisBio Co., Ltd | 2026-01-16 |
| RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure (NCT07366840) | Fudan University | 2026-01-16 |
| Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN) (NCT07053800) | Autolus Limited | 2026-01-16 |
| PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) (NCT07222215) | Kristina A. Fanucci | 2026-01-16 |
| A Study of MHB048C in Patients With Advanced Solid Tumors (NCT07192120) | Minghui Pharmaceutical (Hangzhou) Ltd | 2026-01-16 |
| Ivosidenib as Post-HSCT Maintenance for AML (NCT06707493) | Massachusetts General Hospital | 2026-01-16 |
| A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies (NCT07220616) | Daiichi Sankyo | 2026-01-16 |
| A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. (NCT07235293) | Kahr Bio Australia Pty Ltd | 2026-01-16 |
| Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients (NCT07235176) | Qilu Pharmaceutical Co., Ltd. | 2026-01-16 |
| A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease (NCT07493603) | Xia Liang | 2026-01-16 |
| Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations (NCT06264531) | Fondation Ophtalmologique Adolphe de Rothschild | 2026-01-16 |
| Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies (NCT07276373) | Corcept Therapeutics | 2026-01-16 |
| Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC (NCT07341100) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-01-16 |
| A Study of Revumenib and Mezigdomide in People With Leukemia (NCT07356154) | Memorial Sloan Kettering Cancer Center | 2026-01-16 |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients (NCT07176312) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2026-01-16 |
| Huaier Granule and Proteinuria (NCT07355361) | Fudan University | 2026-01-15 |
| Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management (NCT07279259) | Shanghai East Hospital | 2026-01-15 |
| A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis (NCT04883619) | Janssen Research & Development, LLC | 2026-01-15 |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis (NCT07321873) | Janssen Research & Development, LLC | 2026-01-15 |
| Single vs Triple Hyaluronic Acid in Knee Osteoarthritis (NCT07352540) | University of Erlangen-Nürnberg Medical School | 2026-01-15 |
| Antimicrobial Photodynamic Therapy With ICG-Loaded Nanoparticles for Periodontitis Management (NCT07316023) | Nada Mahmoud Soliman | 2026-01-15 |
| A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11) (NCT07294365) | Dizal Pharmaceuticals | 2026-01-15 |
| Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET) (NCT07243938) | Tao Zhang | 2026-01-15 |
| Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing (NCT07508033) | Al Salam University | 2026-01-15 |
| Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma (NCT07223541) | University of Oklahoma | 2026-01-15 |
| Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants (NCT07363837) | Shanghai Institute Of Biological Products | 2026-01-15 |
| Repurposing Semaglutide for the Treatment of Cocaine Use Disorder (NCT07227948) | The University of Texas Health Science Center, Houston | 2026-01-15 |
| Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter (NCT07296328) | NYU Langone Health | 2026-01-15 |
| A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma (NCT07297212) | BioNTech SE | 2026-01-15 |
| Parathyroid Allotransplant for Treatment of Hypoparathyroidism (NCT06961071) | Peter Stock | 2026-01-15 |
| Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer (NCT07058805) | Olgun Elicin | 2026-01-15 |
| Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) (NCT07222579) | West Virginia University | 2026-01-15 |
| Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma (NCT07349303) | Vastra Gotaland Region | 2026-01-15 |
| PET-Based Imaging of Radiolabeled CIT-013 (NCT07147959) | Citryll BV | 2026-01-15 |
| A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease (NCT06996730) | Banner Health | 2026-01-15 |
| POCUS-Guided Esmolol in Septic Shock: A Pilot RCT (NCT07313605) | John Basmaji | 2026-01-15 |
| Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL (NCT07297914) | Bambino Gesù Hospital and Research Institute | 2026-01-15 |
| Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB) (NCT07292519) | South West Sydney Local Health District | 2026-01-15 |
| Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide (NCT07040592) | Yale University | 2026-01-15 |
| Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved. (NCT07276542) | The Ketamine Research Foundation | 2026-01-15 |
| Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome (NCT04725110) | University of Minnesota | 2026-01-15 |
| A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus (NCT07465224) | Alnylam Pharmaceuticals | 2026-01-15 |
| Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease (NCT07258641) | University Medical Center Groningen | 2026-01-15 |
| Dual-Site Transcranial Magnetic Stimulation of the Supplementary Motor Area and Cerebellum for the Treatment of Essential Tremor. (NCT07344194) | São Paulo State University | 2026-01-15 |
| Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence (NCT05935553) | Hospices Civils de Lyon | 2026-01-15 |
| Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL (NCT07372352) | The First Affiliated Hospital of Soochow University | 2026-01-15 |
| Luspatercept in Patients Affected With Rare Inherited Anemias (NCT07331818) | EuroBloodNet Association | 2026-01-15 |
| Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma (NCT07231250) | Li Zhiming | 2026-01-15 |
| Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. (NCT07289035) | Azienda Ospedaliera Universitaria Integrata Verona | 2026-01-15 |
| Digoxin Medulloblastoma Study (NCT06701812) | H. Lee Moffitt Cancer Center and Research Institute | 2026-01-15 |
| Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma (NCT07324824) | Sun Yat-sen University | 2026-01-14 |
| Allopregnanolone (Zuranolone) in Post-stroke Depression (NCT06759558) | Duke University | 2026-01-14 |
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (NCT06957691) | Shehzad Basaria, M.D. | 2026-01-14 |
| Zuberitamab for EBV Infection Post-Allo-HSCT (NCT07261215) | Institute of Hematology & Blood Diseases Hospital, China | 2026-01-14 |
| DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer (NCT07249372) | NYU Langone Health | 2026-01-14 |
| A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE) (NCT07266090) | Viatris Pharmaceuticals Co., Ltd. | 2026-01-14 |
| Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders (NCT07089121) | Cartesian Therapeutics | 2026-01-14 |
| Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) (NCT07104812) | Mayo Clinic | 2026-01-14 |
| Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial) (NCT07098975) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2026-01-14 |
| Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension (NCT07297797) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-01-14 |
| Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children (NCT07509047) | International Vaccine Institute | 2026-01-13 |
| A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer (NCT06733363) | Roswell Park Cancer Institute | 2026-01-13 |
| Analgesic Efficacy of Pre-Operative Dose of Palmitoylethanolamide in Patients Undergoing Total Knee Arthroplasty (NCT07330765) | Abdelrahman Gaber Sayed Elkhateeb | 2026-01-13 |
| TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) (NCT07190300) | Novartis Pharmaceuticals | 2026-01-13 |
| Investigation of Individualised Antisense Oligonucleotides (ASOs) in People With Unique Genetic Variants Causing Severely Debilitating, Life Threatening (SDLT) Central Nervous System (CNS) Conditions (NCT07410143) | EveryONE Medicines Inc. | 2026-01-13 |
| Hernia Abd Wall Recons - BDE vs Exparel (NCT07518238) | Baylor Research Institute | 2026-01-13 |
| First-in-human Study of 7MW4911 in GI Cancer (NCT07216560) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2026-01-13 |
| This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. (NCT07102342) | iRegene Therapeutics Co., Ltd. | 2026-01-12 |
| A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors (NCT07222969) | Vibrant Sciences Limited | 2026-01-12 |
| Alii Supplement Study (NCT07271316) | Texas Christian University | 2026-01-12 |
| Study of EPI-001 in Patients With Androgenetic Alopecia (NCT07618195) | Epibiotech | 2026-01-12 |
| Neo-adjuvant Immunotherapy in Patients With Localized Melanoma (NCT07230613) | UNICANCER | 2026-01-12 |
| LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC (NCT07325539) | Sun Yat-sen University | 2026-01-12 |
| Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males (NCT07469852) | Liverpool John Moores University | 2026-01-12 |
| A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer (NCT07049055) | Engeneic Pty Limited | 2026-01-12 |
| Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK (NCT06666348) | St. Justine's Hospital | 2026-01-12 |
| Safety Assessment of H2 Inhalation in Patients With Mild Cognitive Impairment (NCT07757542) | University of Ostrava | 2026-01-12 |
| An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma (NCT06444412) | Mayo Clinic | 2026-01-12 |
| Spirulina Derivative for Radiation Esophagitis (NCT07324018) | West China Hospital | 2026-01-12 |
| PATH (Peer Advanced Training in Harm Reduction) to Reducing Burnout Among Peers Who Deliver Harm Reduction Services (R61 Phase Pilot) (NCT07218562) | Chestnut Health Systems | 2026-01-12 |
| Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome (NCT07242638) | Icahn School of Medicine at Mount Sinai | 2026-01-12 |
| Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris (NCT07345390) | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 2026-01-10 |